Management Team

david m. geliebter
sven m. jacobson
janelle r. anderson

Scientific Advisory Board Members

critical diagnostics advisory board members

james v. snider, Ph.D., president of critical diagnostics
james l. januzzi, md
robert l. jesse, md, Ph.D.
richard lee, md
alan stewart maisel, md
david a. morrow, md, mph
william franklin peacock iv, md, facep
alan wu, Ph.D., D.A.B.C.C.
donna j. edmonds

cure therapeutics' advisory board members

jose r. berrezueta, md, Ph.D.
ronald m. burch, md, PH.D.
bruce m gans, md
frank kochinke, Ph.D.
george a. c. murrell, md, Ph.D.
barry p. simmons, md
lee s. simon, md
robert e. baldini, mba (special advisor to the board)
susan l. michlovitz, pt, Ph.D., cht (special advisor to the board)

remedy pharmaceuticals' advisory board members

moses v. chao, Ph.D.
gregory j. del zoppo, md william dalton dietrich, III, Ph.D.
ulrich dirnagl, md
edward d. hall, Ph.D.
j. marc simard, md, Ph.D.
david g. sherman, md
chelsea s. kidwell, md (special advisor to the board)
eugene d. means, md (chief medical officer)

 

 

 

.

 


janelle r. anderson, Ph.D., general manager

Janelle oversees Carrot Capital Healthcare Venture’s portfolio companies. She has a wide-ranging background in both science and business. Before joining Carrot Capital Healthcare Ventures, Janelle spent two years as a Consultant for The Boston Consulting Group, working with many of the firm’s leading healthcare clients. Prior to that, Janelle spent four years as a Research Assistant at Harvard University, While at Harvard, she was the inventor on three patents and author of 11 publications. Janelle earned a B.Sc in Bio-organic Chemistry from McGill University in 1995, an A.M. in Chemistry and Chemical Biology from Harvard University (1998), and was graduated from Harvard University in 2001 with a Ph.D. in Physical Chemistry.

return to beginning >